104 related articles for article (PubMed ID: 24502538)
1. Drug resistance-related miRNAs in hepatocellular cancer.
Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):283-8. PubMed ID: 24502538
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
Giordano S; Columbano A
Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
[TBL] [Abstract][Full Text] [Related]
4. [microRNA: new diagnostic and therapeutic tools in liver disease?].
Gougelet A; Colnot S
Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance-related microRNAs in esophageal cancer.
Hong L; Han Y; Lu Q; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2012 Nov; 12(11):1487-94. PubMed ID: 22827640
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
Hong L; Han Y; Zhang Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Ther Targets; 2013 Sep; 17(9):1073-80. PubMed ID: 23865553
[TBL] [Abstract][Full Text] [Related]
8. microRNA regulation of cell viability and drug sensitivity in lung cancer.
Du L; Pertsemlidis A
Expert Opin Biol Ther; 2012 Sep; 12(9):1221-39. PubMed ID: 22731874
[TBL] [Abstract][Full Text] [Related]
9. Prognosis-related microRNAs in esophageal cancer.
Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Apr; 14(4):483-9. PubMed ID: 24506707
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
11. Implication of microRNAs in drug resistance for designing novel cancer therapy.
Sarkar FH; Li Y; Wang Z; Kong D; Ali S
Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
Borel F; Konstantinova P; Jansen PL
J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
Gorenchtein M; Poh CF; Saini R; Garnis C
J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNA in anticancer drug resistance.
Zheng T; Wang J; Chen X; Liu L
Int J Cancer; 2010 Jan; 126(1):2-10. PubMed ID: 19634138
[TBL] [Abstract][Full Text] [Related]
15. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
[TBL] [Abstract][Full Text] [Related]
16. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
Albulescu R; Neagu M; Albulescu L; Tanase C
Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 2: a therapeutic target in gastric cancer.
Hong L; Han Y; Liu J; Brain L
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):759-65. PubMed ID: 24134151
[TBL] [Abstract][Full Text] [Related]
18. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
Wu Q; Yang Z; Nie Y; Shi Y; Fan D
Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as therapeutic targets and their potential applications in cancer therapy.
Cho WC
Expert Opin Ther Targets; 2012 Aug; 16(8):747-59. PubMed ID: 22690697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
